Skip to main content
NCBI home page
Thorax logoLink to Thorax
. 1996 Oct;51(10):1051–1056. doi: 10.1136/thx.51.10.1051

Functional antagonism: tolerance produced by inhaled beta 2 agonists.

D W Cockcroft 1, V A Swystun 1
PMCID: PMC472666  PMID: 8984693

Full text

PDF
1051

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Ahrens R. C., Bonham A. C., Maxwell G. A., Weinberger M. M. A method for comparing the peak intensity and duration of action of aerosolized bronchodilators using bronchoprovocation with methacholine. Am Rev Respir Dis. 1984 Jun;129(6):903–906. doi: 10.1164/arrd.1984.129.6.903. [DOI] [PubMed] [Google Scholar]
  2. Anderson S. D., Schoeffel R. E., Finney M. Evaluation of ultrasonically nebulised solutions for provocation testing in patients with asthma. Thorax. 1983 Apr;38(4):284–291. doi: 10.1136/thx.38.4.284. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Anderson S., Seale J. P., Ferris L., Schoeffel R., Lindsay D. A. An evaluation of pharmacotherapy for exercise-induced asthma. J Allergy Clin Immunol. 1979 Dec;64(6 Pt 2):612–624. doi: 10.1016/0091-6749(79)90024-1. [DOI] [PubMed] [Google Scholar]
  4. Bhagat R., Kalra S., Swystun V. A., Cockcroft D. W. Rapid onset of tolerance to the bronchoprotective effect of salmeterol. Chest. 1995 Nov;108(5):1235–1239. doi: 10.1378/chest.108.5.1235. [DOI] [PubMed] [Google Scholar]
  5. Bhagat R., Swystun V. A., Cockcroft D. W. Salbutamol-induced increased airway responsiveness to allergen and reduced protection versus methacholine: dose response. J Allergy Clin Immunol. 1996 Jan;97(1 Pt 1):47–52. doi: 10.1016/s0091-6749(96)70282-8. [DOI] [PubMed] [Google Scholar]
  6. Booth H., Fishwick K., Harkawat R., Devereux G., Hendrick D. J., Walters E. H. Changes in methacholine induced bronchoconstriction with the long acting beta 2 agonist salmeterol in mild to moderate asthmatic patients. Thorax. 1993 Nov;48(11):1121–1124. doi: 10.1136/thx.48.11.1121. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. Cockcroft D. W., Killian D. N., Mellon J. J., Hargreave F. E. Bronchial reactivity to inhaled histamine: a method and clinical survey. Clin Allergy. 1977 May;7(3):235–243. doi: 10.1111/j.1365-2222.1977.tb01448.x. [DOI] [PubMed] [Google Scholar]
  8. Cockcroft D. W., McParland C. P., Britto S. A., Swystun V. A., Rutherford B. C. Regular inhaled salbutamol and airway responsiveness to allergen. Lancet. 1993 Oct 2;342(8875):833–837. doi: 10.1016/0140-6736(93)92695-p. [DOI] [PubMed] [Google Scholar]
  9. Cockcroft D. W., McParland C. P., O'Byrne P. M., Manning P., Friend J. L., Rutherford B. C., Swystun V. A. Beclomethasone given after the early asthmatic response inhibits the late response and the increased methacholine responsiveness and cromolyn does not. J Allergy Clin Immunol. 1993 Jun;91(6):1163–1168. doi: 10.1016/0091-6749(93)90319-b. [DOI] [PubMed] [Google Scholar]
  10. Cockcroft D. W., Swystun V. A., Bhagat R. Interaction of inhaled beta 2 agonist and inhaled corticosteroid on airway responsiveness to allergen and methacholine. Am J Respir Crit Care Med. 1995 Nov;152(5 Pt 1):1485–1489. doi: 10.1164/ajrccm.152.5.7582281. [DOI] [PubMed] [Google Scholar]
  11. Finnerty J. P., Wilmot C., Holgate S. T. Inhibition of hypertonic saline-induced bronchoconstriction by terfenadine and flurbiprofen. Evidence for the predominant role of histamine. Am Rev Respir Dis. 1989 Sep;140(3):593–597. doi: 10.1164/ajrccm/140.3.593. [DOI] [PubMed] [Google Scholar]
  12. Gibson G. J., Greenacre J. K., König P., Conolly M. E., Pride N. B. Use of exercise challenge to investigate possible tolerance to beta-adrenoceptor stimulation in asthma. Br J Dis Chest. 1978 Jul;72(3):199–206. doi: 10.1016/0007-0971(78)90042-6. [DOI] [PubMed] [Google Scholar]
  13. Grove A., Lipworth B. J. Bronchodilator subsensitivity to salbutamol after twice daily salmeterol in asthmatic patients. Lancet. 1995 Jul 22;346(8969):201–206. doi: 10.1016/s0140-6736(95)91265-7. [DOI] [PubMed] [Google Scholar]
  14. Inman M. D., O'Byrne P. M. The effect of regular inhaled albuterol on exercise-induced bronchoconstriction. Am J Respir Crit Care Med. 1996 Jan;153(1):65–69. doi: 10.1164/ajrccm.153.1.8542164. [DOI] [PubMed] [Google Scholar]
  15. Kalra S., Swystun V. A., Bhagat R., Cockcroft D. W. Inhaled corticosteroids do not prevent the development of tolerance to the bronchoprotective effect of salmeterol. Chest. 1996 Apr;109(4):953–956. doi: 10.1378/chest.109.4.953. [DOI] [PubMed] [Google Scholar]
  16. Kerrebijn K. F., van Essen-Zandvliet E. E., Neijens H. J. Effect of long-term treatment with inhaled corticosteroids and beta-agonists on the bronchial responsiveness in children with asthma. J Allergy Clin Immunol. 1987 Apr;79(4):653–659. doi: 10.1016/s0091-6749(87)80163-x. [DOI] [PubMed] [Google Scholar]
  17. Kraan J., Koëter G. H., van der Mark T. W., Boorsma M., Kukler J., Sluiter H. J., De Vries K. Dosage and time effects of inhaled budesonide on bronchial hyperreactivity. Am Rev Respir Dis. 1988 Jan;137(1):44–48. doi: 10.1164/ajrccm/137.1.44. [DOI] [PubMed] [Google Scholar]
  18. Lai C. K., Twentyman O. P., Holgate S. T. The effect of an increase in inhaled allergen dose after rimiterol hydrobromide on the occurrence and magnitude of the late asthmatic response and the associated change in nonspecific bronchial responsiveness. Am Rev Respir Dis. 1989 Oct;140(4):917–923. doi: 10.1164/ajrccm/140.4.917. [DOI] [PubMed] [Google Scholar]
  19. Manolitsas N. D., Wang J., Devalia J. L., Trigg C. J., McAulay A. E., Davies R. J. Regular albuterol, nedocromil sodium, and bronchial inflammation in asthma. Am J Respir Crit Care Med. 1995 Jun;151(6):1925–1930. doi: 10.1164/ajrccm.151.6.7767541. [DOI] [PubMed] [Google Scholar]
  20. O'Connor B. J., Aikman S. L., Barnes P. J. Tolerance to the nonbronchodilator effects of inhaled beta 2-agonists in asthma. N Engl J Med. 1992 Oct 22;327(17):1204–1208. doi: 10.1056/NEJM199210223271704. [DOI] [PubMed] [Google Scholar]
  21. Pauwels R., Joos G., Van der Straeten M. Bronchial hyperresponsiveness is not bronchial hyperresponsiveness is not bronchial asthma. Clin Allergy. 1988 Jul;18(4):317–321. doi: 10.1111/j.1365-2222.1988.tb02878.x. [DOI] [PubMed] [Google Scholar]
  22. Ramage L., Lipworth B. J., Ingram C. G., Cree I. A., Dhillon D. P. Reduced protection against exercise induced bronchoconstriction after chronic dosing with salmeterol. Respir Med. 1994 May;88(5):363–368. doi: 10.1016/0954-6111(94)90042-6. [DOI] [PubMed] [Google Scholar]
  23. Taylor D. R., Sears M. R., Cockcroft D. W. The beta-agonist controversy. Med Clin North Am. 1996 Jul;80(4):719–748. doi: 10.1016/s0025-7125(05)70465-x. [DOI] [PubMed] [Google Scholar]
  24. Vathenen A. S., Knox A. J., Higgins B. G., Britton J. R., Tattersfield A. E. Rebound increase in bronchial responsiveness after treatment with inhaled terbutaline. Lancet. 1988 Mar 12;1(8585):554–558. doi: 10.1016/s0140-6736(88)91352-9. [DOI] [PubMed] [Google Scholar]
  25. Verberne A. A., Hop W. C., Creyghton F. B., van Rooij R. W., van den Berg M., de Jongste J. C., Kerrebijn K. F. Airway responsiveness after a single dose of salmeterol and during four months of treatment in children with asthma. J Allergy Clin Immunol. 1996 Apr;97(4):938–946. doi: 10.1016/s0091-6749(96)80068-6. [DOI] [PubMed] [Google Scholar]
  26. Wahedna I., Wong C. S., Wisniewski A. F., Pavord I. D., Tattersfield A. E. Asthma control during and after cessation of regular beta 2-agonist treatment. Am Rev Respir Dis. 1993 Sep;148(3):707–712. doi: 10.1164/ajrccm/148.3.707. [DOI] [PubMed] [Google Scholar]
  27. Yates D. H., Sussman H. S., Shaw M. J., Barnes P. J., Chung K. F. Regular formoterol treatment in mild asthma. Effect on bronchial responsiveness during and after treatment. Am J Respir Crit Care Med. 1995 Oct;152(4 Pt 1):1170–1174. doi: 10.1164/ajrccm.152.4.7551366. [DOI] [PubMed] [Google Scholar]

Articles from Thorax are provided here courtesy of BMJ Publishing Group

RESOURCES